25602-68-0 Usage
Description
Nortropinone hydrochloride, a metabolite of Tropinone, is a white to off-white solid with significant applications in the pharmaceutical industry. It serves as an inhibitor for reactions involving the 11 beta-hydroxysteroid dehydrogenase type 1 enzyme, making it a valuable component in drug discovery. Its role as a linker or building block allows for the exploration of a wide range of therapeutics and drugs.
Uses
Used in Drug Discovery:
Nortropinone hydrochloride is used as a building block for the development of various therapeutics and drugs. Its ability to act as an inhibitor in reactions involving the 11 beta-hydroxysteroid dehydrogenase type 1 enzyme makes it a crucial component in the process of drug discovery.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Nortropinone hydrochloride is used as an inhibitor for specific enzymatic reactions. Its chemical properties and inhibitory function contribute to the development of targeted treatments and medications.
Used in Research and Development:
Nortropinone hydrochloride is also utilized in research and development settings, where it serves as a valuable tool for studying the mechanisms of enzymatic reactions and the potential for new drug therapies. Its role as a linker component enables the exploration of various chemical structures and their effects on biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 25602-68-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,6,0 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 25602-68:
(7*2)+(6*5)+(5*6)+(4*0)+(3*2)+(2*6)+(1*8)=100
100 % 10 = 0
So 25602-68-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H11NO.ClH/c9-7-3-5-1-2-6(4-7)8-5;/h5-6,8H,1-4H2;1H
25602-68-0Relevant articles and documents
RET inhibitor and pharmaceutical composition and application thereof
-
Paragraph 0356-0359, (2021/10/27)
The invention belongs to the field of medicines, and relates to an RET inhibitor and a pharmaceutical composition and application thereof. Specifically, the invention relates to a compound as shown in a formula (I), or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug of the compound as shown in the formula (I). The invention also relates to pharmaceutical compositions comprising the compounds, and uses of the compounds and pharmaceutical compositions thereof in the preparation of a medicine which is especially used for the treatment and prevention of RET-related diseases and disorders, including cancers, irritable bowel syndrome and/or pain associated with irritable bowel syndrome.
HETEROARYLTHIOMETHYL PYRIDINE DERIVATIVE
-
Page/Page column 38, (2010/11/17)
The present invention relates to a compound represented by a formula (I): wherein X is a group represented by or the like; Y is a group represented by or the like; and Ar1 is a group represented by or a pharmaceutically acceptable salt thereof.
MODULATORS OF MUSCARINIC RECEPTORS
-
Page/Page column 70, (2010/11/08)
The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.